This compound is a cyclic peptide that acts as an endothelin A receptor antagonist. It is used in pharmaceutical research as a laboratory reagent for studying endothelin-related pathways.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Cyclo(D-trp-D-asp-pro-D-val-leu)?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Clazosentan
pharmaceutical raw material
[4-(hydroxymethyl)phenoxymethyl]polystyrene
pharmaceutical raw material
Irinotecan hydrochloride trihydrate
pharmaceutical raw material
Cyclopropanecarboxamide, N-[[[(1R,2R)-2-[[4,4-difluoro-4-(3-hydroxy-2-quinoxalinyl)-2-buten-1-yl]oxy]cyclopentyl]oxy]carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-2-(difluoromethyl)-N-[(1-methylcyclopropyl)sulfonyl]-, cyclic (1→2)-ether,
pharmaceutical raw material
(RS)-nefopam
pharmaceutical raw material
2-[(3R,6R,9S,12R,15S)-6-(1H-indol-3-ylmethyl)-9-(2-methylpropyl)-2,5,8,11,14-pentaoxo-12-propan-2-yl-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-3-yl]acetic acid
VYCMAAOURFJIHD-PJNXIOHISA-N
CC(C)C[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(=O)N1)C(C)C)CC(=O)O)CC3=CNC4=CC=CC=C43
Sourcing Cyclo(D-trp-D-asp-pro-D-val-leu)?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.